Core Laboratories
CLB
196 hedge funds and large institutions have $1.42B invested in Core Laboratories in 2022 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 80 increasing their positions, 41 reducing their positions, and 19 closing their positions.
711% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $1.5M
126% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 19
95% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 41
49% more capital invested
Capital invested by funds: $956M → $1.42B (+$464M)
13% more funds holding
Funds holding: 174 → 196 (+22)
4.55% more ownership
Funds ownership: 92.56% → 97.11% (+4.6%)
Top Buyers
| 1 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$12M |
| 2 |
CPH
C Partners Holding
Zurich,
Switzerland
|
+$11.8M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$11.1M |
| 4 |
VanEck Associates
New York
|
+$10.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.94M |
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$18.6M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$9.39M |
| 3 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$3.41M |
| 4 |
Two Sigma Investments
New York
|
-$3.36M |
| 5 |
JP Morgan Chase
New York
|
-$2.62M |
CLB Hedge Fund Activity: Q1 2022 in Review
196 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2022, worth a combined $1.42B — up 49% from $956M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CLB positions and 19 closed out — a net gain of 24 holders — while 80 added to existing stakes and 41 trimmed.
The largest buyer was Congress Asset Management, opening a new position worth an estimated $12M. The largest seller was Marshall Wace, exiting entirely with an estimated $18.6M sold.
- 196 institutional investors held Core Laboratories (CLB) as of Q1 2022, up from 174 in Q4 2021.
- Funds reported $1.42B of Core Laboratories stock for Q1 2022, up 49% quarter-over-quarter.
- 43 funds opened new Core Laboratories positions in Q1 2022 and 19 closed out, a net change of +24 holders.
- The largest Core Laboratories buyer in Q1 2022 was Congress Asset Management, an estimated $12M added.
- The largest Core Laboratories seller in Q1 2022 was Marshall Wace, an estimated $18.6M sold.
Based on aggregated 13F filings for Q1 2022.